Advances in the understanding of the pathophysiology of sepsis have occurred in the last decade. Previously, sepsis was viewed primarily as an inflammatory disorder. More recent studies indicate ...

Adrenomed’s goal is to fill the gap in patient treatment further downstream of inflammation with Adrecizumab, the first sepsis therapy candidate to target an important causal pathophysiology of ...

“Despite the increased understanding of sepsis pathophysiology and the application of advanced clinical treatments, sepsis remains a major cause of health loss worldwide with a high health-related ...

Despite similar clinical presentations, the molecular and cellular processes that elicit the sepsis response differ depending on whether the organism is gram-negative, gram-positive, fungal ...